TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35675498

Group type: EXPERIMENTAL
Intervention: Intensive sliding scale insulin (correction for BG >140 mg/dL)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Nonintensive sliding scale insulin (correction for BG >260 mg/dL)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Intensive sliding scale insulin
Number of subjects: 215

Group type: COMPARATOR
Intervention: Nonintensive sliding scale insulin
Number of subjects: 215
Study: 33938259

Group type: EXPERIMENTAL
Intervention: Self-reported adherence
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Self-monitored adherence
Number of subjects: 214

Group type: COMPARATOR
Intervention: Exposure-based adherence
Number of subjects: 214
Study: 32902387

Group type: EXPERIMENTAL
Intervention: Robot-assisted care pathway (n=37) using a social robot conducting a 36-item PROM
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (n=38) using professional interviews
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Caregivers in the robot-assisted care pathway (n=30)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Caregivers in the control group (n=35)
Number of subjects: 75
Study: 35902705

Group type: EXPERIMENTAL
Intervention: Omega-3 supplements
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34976760

Group type: EXPERIMENTAL
Intervention: Oral midazolam with intranasal S-ketamine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral midazolam
Number of subjects: 80
Study: 33059647

Group type: EXPERIMENTAL
Intervention: Multi-interventional program including mechanical bowel preparation with oral antibiotics, tailored full splenic flexure mobilization, and intraoperative fluorescence angiography using indocyanine green.
Number of subjects: 488

Group type: COMPARATOR
Intervention: Current local practice (control cohort).
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Multi-interventional program.
Number of subjects: 488
Study: 36011647

Group type: EXPERIMENTAL
Intervention: I1 (pedometer and goal of 10,000 steps/day)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: I2 (pedometer without a goal)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: I1 and I2
Number of subjects: 270
Study: 32702701

Group type: EXPERIMENTAL
Intervention: Pneumatic lithotripsy (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ho:YAG laser lithotripsy (group B)
Number of subjects: 50
Study: 35340337

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of lidocaine (Group L)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transverse abdominal plane block (Group T)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 99
Study: 33476177

Group type: EXPERIMENTAL
Intervention: iOS app support
Number of subjects: 34

Group type: COMPARATOR
Intervention: Written homework instructions
Number of subjects: 34
Study: 35835822

Group type: EXPERIMENTAL
Intervention: Third dose of BBV152 (COVAXIN®)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two doses of BBV152 (COVAXIN®)
Number of subjects: 0
Study: 34933950

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus general care (HGC)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Chloroquine plus general care (CGC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Only general care (OGC)
Number of subjects: 150
Study: 35176913

Group type: EXPERIMENTAL
Intervention: Advocacy education curriculum
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no advocacy education)
Number of subjects: 80
Study: 33581715

Group type: EXPERIMENTAL
Intervention: Lifestyle and risk factor modification intervention programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard healthcare
Number of subjects: 0
Study: 34995522

Group type: EXPERIMENTAL
Intervention: IOL repositioning by scleral suturing
Number of subjects: 100

Group type: COMPARATOR
Intervention: IOL exchange with retropupillary fixation of an iris-claw lens
Number of subjects: 100
Study: 33915091

Group type: EXPERIMENTAL
Intervention: Laparoscopic pancreatoduodenectomy (LPD)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Open pancreatoduodenectomy (OPD)
Number of subjects: 656
Study: 35584181

Group type: EXPERIMENTAL
Intervention: MOSAIC Plus intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional MOSAIC intervention
Number of subjects: 40
Study: 33148725

Group type: EXPERIMENTAL
Intervention: Financial incentive (shopping points)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 72
Study: 33683617

Group type: EXPERIMENTAL
Intervention: Standard care + virtual reality
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 63
Study: 32213443

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) concentration in Peripheral Blood Mononuclear Cells (Cu.PBMC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Levetiracetam (LEV) concentration in serum (Cu.serum)
Number of subjects: 70
Study: 36064489

Group type: EXPERIMENTAL
Intervention: Interdisciplinary treatments including psychology, physiotherapy, and medical interventions for up to 12 weeks
Number of subjects: 15
Study: 32222056

Group type: EXPERIMENTAL
Intervention: Insulin pump education curriculum
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitor (CGM) education curriculum
Number of subjects: 64
Study: 35759843

Group type: EXPERIMENTAL
Intervention: Grade III lumbar rotational mobilization
Number of subjects: 42

Group type: COMPARATOR
Intervention: Grade I lumbar rotational mobilization (Control)
Number of subjects: 42
Study: 33640008

Group type: EXPERIMENTAL
Intervention: Machine learning model for predicting flare probability after tapering bDMARDs
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Percent dose change of bDMARDs
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Clinical disease activity (DAS-28 ESR)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Disease duration
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Inflammatory markers
Number of subjects: 41
Study: 33106259

Group type: EXPERIMENTAL
Intervention: Continuous infusion (CON) of fosfomycin at 1 g/h preceded by a loading dose of 8 g over 30 min
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intermittent infusion (INT) of fosfomycin at 8 g over 30 min every 8 h
Number of subjects: 8
Study: 34305239

Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS), 10 sessions, 20 minutes each, anode at F3, cathode at F4, current intensity 1.5 mA
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 33361166

Group type: EXPERIMENTAL
Intervention: InnoSEAL + TRB
Number of subjects: 714

Group type: COMPARATOR
Intervention: TRB alone
Number of subjects: 714
Study: 33307226

Group type: EXPERIMENTAL
Intervention: ADAPT+ (multi-family behavioral obesity intervention with mindfulness strategies)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 0
Study: 32383366

Group type: EXPERIMENTAL
Intervention: Lactobacillus pentosus (1.0 × 10^10 CFU daily for 12 weeks)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Lactobacillus pentosus
Number of subjects: 82
Study: 35869497

Group type: EXPERIMENTAL
Intervention: NeuroSAFE robotic-assisted radical prostatectomy (RARP)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Standard robotic-assisted radical prostatectomy (RARP)
Number of subjects: 404
Study: 32143652

Group type: EXPERIMENTAL
Intervention: Spontaneous timed AVAPS (ST/AVAPS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bilevel positive airway pressure (ST/BiPAP)
Number of subjects: 40
Study: 33905011

Group type: EXPERIMENTAL
Intervention: Extraoral photobiomodulation (EOPBM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intraoral photobiomodulation (IOPBM)
Number of subjects: 60
Study: 32359046

Group type: EXPERIMENTAL
Intervention: Single-serving edible
Number of subjects: 26894

Group type: EXPERIMENTAL
Intervention: Unit-dose packaging
Number of subjects: 26894

Group type: COMPARATOR
Intervention: Multiserving edible (control condition)
Number of subjects: 26894
Study: 34952751

Group type: EXPERIMENTAL
Intervention: ccIIV4
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: LAIV4
Number of subjects: 198
Study: 32387453

Group type: EXPERIMENTAL
Intervention: irinotecan/panitumumab (IrPan)
Number of subjects: 1180

Group type: COMPARATOR
Intervention: irinotecan
Number of subjects: 1180
Study: 36803399

Group type: EXPERIMENTAL
Intervention: Overground walking with paretic lower limb loading
Number of subjects: 48

Group type: COMPARATOR
Intervention: Overground walking without paretic lower limb loading
Number of subjects: 48
Study: 34516429

Group type: EXPERIMENTAL
Intervention: Dental unit waterlines with 5-15% sodium hypochlorite
Number of subjects: 82

Group type: COMPARATOR
Intervention: Dental specialty
Number of subjects: 82

Group type: COMPARATOR
Intervention: Time of sample collection
Number of subjects: 82

Group type: COMPARATOR
Intervention: Older age of dental unit
Number of subjects: 82
Study: 32160019

Group type: EXPERIMENTAL
Intervention: C12 (0.4 kcal/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Leu (0.45 kcal/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: C12+Leu (0.85 kcal/min)
Number of subjects: 16
Study: 35382772

Group type: EXPERIMENTAL
Intervention: Midwifery-led counseling (six 60-90 min sessions, twice a week)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Midwifery-led counseling
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 34166434

Group type: EXPERIMENTAL
Intervention: High academic performance
Number of subjects: 1287

Group type: COMPARATOR
Intervention: Low academic performance (failing a subject or repeating a year)
Number of subjects: 1287

Group type: EXPERIMENTAL
Intervention: Emotional intelligence (stress management and mood)
Number of subjects: 1287
Study: 33238242

Group type: EXPERIMENTAL
Intervention: Moderate wrapping pressure
Number of subjects: 19

Group type: COMPARATOR
Intervention: High wrapping pressure
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (loose band application)
Number of subjects: 19
Study: 35685654

Group type: EXPERIMENTAL
Intervention: iDose4 reconstruction algorithm, tube voltage 120 kV
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: iDose4 reconstruction algorithm, tube voltage 100 kV
Number of subjects: 90

Group type: COMPARATOR
Intervention: Filtered back projection (FBP) reconstruction algorithm, tube voltage 120 kV
Number of subjects: 90
Study: 33653354

Group type: EXPERIMENTAL
Intervention: Task-shifting asthma education intervention delivered by lay-educators
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pre-intervention training and support for lay-educators
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Challenges faced by participants prior to the intervention
Number of subjects: 43
Study: 35701094

Group type: EXPERIMENTAL
Intervention: Lumen-apposing metal stents (LAMS)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Double-pigtail plastic stents
Number of subjects: 53
Study: 33692191

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention to implement guideline recommendations for low back pain care
Number of subjects: 4491
Study: 35899345

Group type: EXPERIMENTAL
Intervention: Community-based self-management group intervention
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 500
Study: 33431510

Group type: EXPERIMENTAL
Intervention: Mendelian randomization studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized trials
Number of subjects: 0
Study: 34284845

Group type: EXPERIMENTAL
Intervention: Care-seeking for noncommunicable diseases
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Diarrhea in children
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Cough/difficulty breathing
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Pregnancy complications
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Emotional and psychological complaints
Number of subjects: 600
Study: 34492306

Group type: EXPERIMENTAL
Intervention: iSIPsmarter intervention
Number of subjects: 244

Group type: COMPARATOR
Intervention: static Participant Education website
Number of subjects: 244
Study: 34343968

Group type: EXPERIMENTAL
Intervention: PCA (Patient-Controlled Analgesia)
Number of subjects: 214

Group type: COMPARATOR
Intervention: non-PCA (Hydromorphone Titration by Healthcare Provider)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: PCA
Number of subjects: 214

Group type: COMPARATOR
Intervention: non-PCA
Number of subjects: 214
Study: 32171086

Group type: EXPERIMENTAL
Intervention: Deep-learning computer-aided detection system (CADe)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard colonoscopy without CADe)
Number of subjects: 0
Study: 35770339

Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) imaging system during video-assisted thoracoscopic surgery radical esophagectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standard procedure without ICG)
Number of subjects: 40
Study: 34471087

Group type: EXPERIMENTAL
Intervention: Danhong injection (DHI) for 14 days
Number of subjects: 920

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 920
Study: 32521115

Group type: EXPERIMENTAL
Intervention: Suture ligation with suspension
Number of subjects: 300

Group type: COMPARATOR
Intervention: Endoscopic stapling
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cut and suture ligation
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Nerve sparing
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-nerve sparing
Number of subjects: 300
Study: 35198639

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol
Number of subjects: 170

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 170
Study: 32210467

Group type: EXPERIMENTAL
Intervention: Parent food frequency questionnaire (FFQ)
Number of subjects: 590
Study: 34174082

Group type: COMPARATOR
Intervention: Neutralizing antibody (nAb) titers
Number of subjects: 0
Study: 34052249

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE) - 45-min treadmill run at 60% VO2max
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE) - three sets of eight repetitions, seven weight-lifting exercises
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (CON) - 45-min no-exercise control
Number of subjects: 12
Study: 36027311

Group type: EXPERIMENTAL
Intervention: High salt intake (HIS: 200 mmol/day of sodium tablets)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low salt diet (LSD: 50 mmol/day)
Number of subjects: 15
Study: 32505529

Group type: EXPERIMENTAL
Intervention: Piezoelectric (PE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional drills (CD)
Number of subjects: 30
Study: 35718438

Group type: EXPERIMENTAL
Intervention: Zygomatic implants
Number of subjects: 0

Group type: COMPARATOR
Intervention: All-on-Four concept
Number of subjects: 0
Study: 34000130

Group type: EXPERIMENTAL
Intervention: Pain Frequency, Intensity, and Burden Scale (P-FIBS)
Number of subjects: 4923

Group type: EXPERIMENTAL
Intervention: Pain
Number of subjects: 4923
Study: 32827053

Group type: EXPERIMENTAL
Intervention: Dissection with LigaSure Impact™
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional dissection
Number of subjects: 102
Study: 36056328

Group type: EXPERIMENTAL
Intervention: Post-Code Pause (PCP)
Number of subjects: 655

Group type: COMPARATOR
Intervention: Debriefing In Situ Conversation after Emergent Resuscitation Now (DISCERN)
Number of subjects: 655
Study: 33077560

Group type: EXPERIMENTAL
Intervention: Care Group Intervention
Number of subjects: 0
Study: 33401270

Group type: EXPERIMENTAL
Intervention: ENB plus CBCT
Number of subjects: 62

Group type: COMPARATOR
Intervention: ENB alone
Number of subjects: 62
Study: 32139188

Group type: EXPERIMENTAL
Intervention: Patients with contralateral OA
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Patients with contralateral THA in place
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Distance from the tip of the trochanter to the top of the femoral head
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Increased age
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 241
Study: 34363901

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35671829

Group type: EXPERIMENTAL
Intervention: Crushed tablets of prasugrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Integral tablets of prasugrel
Number of subjects: 0
Study: 33740926

Group type: EXPERIMENTAL
Intervention: Avapritinib (300 mg or 400 mg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Other tyrosine kinase inhibitors (TKIs)
Number of subjects: 75
Study: 36047381

Group type: EXPERIMENTAL
Intervention: Empowering Community Pharmacists program
Number of subjects: 55
Study: 34158310

Group type: EXPERIMENTAL
Intervention: Rounding checklist intervention
Number of subjects: 420
Study: 36223849

Group type: EXPERIMENTAL
Intervention: 0.19-mg fluocinolone acetonide (FAc) intravitreal implant
Number of subjects: 159
Study: 33827306

Group type: EXPERIMENTAL
Intervention: 5 µg Dex intrathecally
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 5 µg sufentanil intrathecally
Number of subjects: 108

Group type: COMPARATOR
Intervention: 1 mL saline (0.9%) intrathecally
Number of subjects: 108
Study: 32223057

Group type: EXPERIMENTAL
Intervention: Western diet‐like high-carbohydrate (WDHC) meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Western diet‐like high-fat (WDHF) meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MED) meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All meals
Number of subjects: 0
Study: 36008060

Group type: EXPERIMENTAL
Intervention: Nurse-led coaching of self-care agency intervention during hospitalisation and home supervision after discharge
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group received routine nursing during hospitalisation and conventional family care after discharge without regular supervision
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nurse-led coaching of self-care agency intervention
Number of subjects: 60
Study: 33685923

Group type: EXPERIMENTAL
Intervention: Weight loss through referral to community weight-loss programmes
Number of subjects: 2041
Study: 36398411

Group type: EXPERIMENTAL
Intervention: myAlgos full version
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control version
Number of subjects: 80
Study: 32003800

Group type: EXPERIMENTAL
Intervention: Years of schooling (SD = 3.6 years)
Number of subjects: 54062

Group type: EXPERIMENTAL
Intervention: Intelligence (SD = 15 points on intelligence test)
Number of subjects: 54062

Group type: COMPARATOR
Intervention: Intelligence
Number of subjects: 54062

Group type: COMPARATOR
Intervention: Educational attainment
Number of subjects: 54062
Study: 34970912

Group type: EXPERIMENTAL
Intervention: Highest tertile of serum GDF‐15 levels
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Log-transformed GDF‐15 levels
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Serum GDF‐15 levels
Number of subjects: 572
Study: 33002924

Group type: EXPERIMENTAL
Intervention: Capnogram waveform-guided bronchial cuff inflation (capno group, n = 27)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Pressure-guided bronchial cuff inflation (pressure group, n = 29)
Number of subjects: 64
Study: 32843240

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy delivered in person
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy delivered via telemedicine
Number of subjects: 136
Study: 35618557

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 52954

Group type: EXPERIMENTAL
Intervention: DTP vaccination
Number of subjects: 52954
Study: 33715477

Group type: EXPERIMENTAL
Intervention: Lateral wedge insoles (2, 4, 6, 8, or 10 degrees)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Neutral insoles (0 degrees)
Number of subjects: 38
Study: 32093379

Group type: EXPERIMENTAL
Intervention: Resveratrol (manufacturer’s recommended dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 36460265

Group type: EXPERIMENTAL
Intervention: Incentives Arm
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Tailored Messages Arm
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Combined Arm
Number of subjects: 380

Group type: COMPARATOR
Intervention: Control Arm
Number of subjects: 380
Study: 33442932

Group type: EXPERIMENTAL
Intervention: Transaortic (TAo) approach
Number of subjects: 282

Group type: COMPARATOR
Intervention: Transapical (TA) approach
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: New York Heart Association III–IV
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Chronic renal failure
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Previous transient ischemic attack/stroke
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Sapien-3 device
Number of subjects: 282
Study: 35900311

Group type: EXPERIMENTAL
Intervention: GCS (Gemcitabine, Cisplatin plus S-1)
Number of subjects: 246

Group type: COMPARATOR
Intervention: GC (Gemcitabine, Cisplatin)
Number of subjects: 246
Study: 34332818

Group type: EXPERIMENTAL
Intervention: Pain management education (10 minutes of education and a pain management reference card)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard care (no additional education)
Number of subjects: 174
Study: 34167897

Group type: EXPERIMENTAL
Intervention: 900 mg nolasiban
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 1800 mg nolasiban
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 32046991

Group type: EXPERIMENTAL
Intervention: Digitally assisted nursing observations
Number of subjects: 755
Study: 35288393

Group type: EXPERIMENTAL
Intervention: Emicizumab (3 mg/kg once per week for the first 4 weeks, followed by 1.5 mg/kg once per week, 3 mg/kg once every 2 weeks, or 6 mg/kg once every 4 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Emicizumab
Number of subjects: 20
Study: 35084163

Group type: EXPERIMENTAL
Intervention: Maximal Vertical Jump (VJ)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Multiple Jump Series (MJ)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 69